Reports say U.S. Food and Drug Governance Commissioner Marty Makary is expected to be removed. The Wall Street Journal reports the firing is essentially settled, while the New York times and The Washington Post also report he is on his way out, though CNN indicates it may not be finalized.<\/p>\n

Supporters, including pro-life leaders<\/a>, are calling for Makary\u2019s dismissal. They accuse him of moving too slowly on a safety review of mifepristone, and Susan B. Anthony Pro-Life America president Marjorie Dannenfelser has demanded his removal. The reporting also points to internal conflict: the Journal cites repeated sparring between Makary and health department\/White House officials, including a dispute over approving flavored vape products after earlier concerns about youth vaping.<\/p>\n

The Washington post suggests any departure could come with broader FDA management changes, but no replacement has been named. A White House representative denies specifics, and CNN reports Makary appears to be resisting the idea that he\u2019ll be fired. <\/p>\n